Composition for treating inflammatory bowel disease

A technology for formulating prescriptions for inflammatory bowel disease, applied in anti-inflammatory agents, drug combinations, pharmaceutical formulas, etc., can solve problems such as unsatisfactory effects and large side effects, and achieve human life extension, good therapeutic effects, enhanced blood supply and The effect of oxygen supply

Inactive Publication Date: 2016-03-23
何松庆
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] 1. Production of 0.6 grams of Danshen, 1.2 grams of glutamine, 0.5 grams of threonine, 0.6 grams of serine, 0.06 grams of cysteine, 50 mg of vitamin C, 4 mg of vitamin E, 0.1 mg of vitamin A, and 0.6 mg of β-carotene As a chewable tablet, 2 to 4 times a day.

[0027] 2. Production of 0.3 grams of Danshen, 0.6 grams of glutamine, 0.25 grams of threonine, 0.3 grams of serine, 0.03 grams of cysteine, 25 milligrams of vitamin C, 2 milligrams of vitamin E, 0.05 milligrams of vitamin A, and 0.3 milligrams of beta-carotene As a chewable tablet, 2 to 4 times a day.

[0028] 3. Salvia miltiorrhiza 0.6 grams, glutamine 1.2 grams, threonine 0.5 grams, serine 0.6 grams, cysteine ​​0.06 grams, vitamin C 50 mg, vitamin E 4 mg, vitamin A 0.1 mg, β-carotene 0.6 mg Injection, 2 to 4 times a day.

[0029] 4. Production of 0.3 grams of Salvia miltiorrhiza, 0.6 grams of glutamine, 0.25 grams of threonine, 0.3 grams of serine, 0.03 grams of cysteine, 25 milligrams of vitamin C, 2 milligra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a composition for treating inflammatory bowel disease and belongs to the field of medicines. The composition comprises the following components: salvia miltiorrhiza, glutamine, threonine, serine, cysteine, vitamins C, E and A, and beta-carotene. The salvia miltiorrhiza has the efficacy of enhancing blood supply and oxygen supply of human bodies; glutamine is a main energy source for the intestinal mucosa; threonine, serine and cysteine are main components of mucoprotein; the vitamins C, E and A and beta-carotene have the effects of inhibiting activity of oxygen free radicals, removing oxygen free radicals and protecting human cells. The composition disclosed by the invention provides nutrients, oxygen and raw materials for goblet cells for development, renewal and repairing as well as secretion of mucoprotein to form the intestinal surface mucous layer barrier. The composition has an obvious effect for termination of inflammation, repairing of intestinal tissue and establishment of the normal intestinal surface mucous layer barrier of a human body and is an effective composition for treating the inflammatory bowel disease.

Description

technical field [0001] The invention relates to a combination formula of Chinese medicinal materials, amino acids and vitamins for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61P1/00A61P29/00A61K31/198A61K31/07A61K31/015A61K31/355A61K31/375
CPCA61K9/0056A61K31/015A61K31/07A61K31/198A61K31/355A61K31/375A61K36/537A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap